Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

See introductory video with welcome to the ICR 

See full video covering all of ICR and its Departments 

Publication overview

Annual reports


Current news and events

New Nature paper:Eating droplets piecemeal or in one big bite

Scientists from Harald Stenmark’s group involved in the international study
Scientists from Harald Stenmark’s group involved in the international study

Autophagy, ‘self-eating’, is the process by which cells capture and degrade components in their own interior that are harmful or superfluous, in order to recycle, detoxify and reuse them. In recent years, it was discovered that an important player in cells are fluid droplets - like drops of oil in water - that are enriched with proteins to perform various functions. Now, in a new paper published in Nature, CanCell scientists have collaborated with an international team to unravel how autophagy can capture droplets of “fluid” proteins inside the cell. The research team has uncovered the physics behind droplet autophagy, and how droplets also can serve as platform to enable autophagy of other cellular components. 

The new Scientific Advisory Board for the Institute for Cancer Research meets

The Institute for Cancer Research has recently renewed and rotated its Scientific Advisory Board that provide regular reviews of scientific output,  quality and performance and gives advice on research strategy.

The SAB consist of six highly distinguished scientists recruited from different institutions in Sweden, Denmark, Great Britain, The Netherlands and Austria. They represent a variety of different scientific backgrounds in basic, translational and clinical cancer research, collectively have a great set of complementary competencies and a long track record of scientific and strategic leadership experience. They  are thus very well equipped for evaluating the scientific activity at the institute.

Inside the head of a researcher: Cancer is a genetic disease

Vessela N. Kristensen
Vessela N. Kristensen

Last autumn Vessela Kristensen acceded the position of head of Division of Research and Development and Head of research at the Department of Medical Genetics, Clinic for Laboratory medicine, OUS.

With eagerness and ambition, she has already taken hold of what will be the main focus the next years.

- We want to make the good work within the field of medical genetics more visible and cooperate tighter across all professional environments within the hospital so that we together improve the service we offer our patients with cancer and other diseases.

In Nature:The Olweus lab reports that translational mistakes in cancer can be targets of immunotherapy

Maarja Laos (left) and Johanna Olweus
Maarja Laos (left) and Johanna Olweus

A combined research effort by scientists at the Weizmann Institute of Science in Israel and researchers at the Netherlands Cancer Institute in Amsterdam and Oslo University Hospital/University of Oslo, Norway, shows exactly how tumors can overcome hurdles that occur when starved for certain building blocks used in protein synthesis.  These results could be exploited for the development of new immunotherapies, as they unravel a completely new class of therapeutic targets that cannot be detected at the genomic (DNA) level. The study was published in Nature Dec 17.
The findings were presented in a full-page story in the major national newspaper VG on January 7th.

Anita Sveen awarded the ICR "Researcher of the Year" Prize for 2020

Anita Sveen (photo: Per M. Didriksen)
Anita Sveen (photo: Per M. Didriksen)

Anita Sveen (39) – senior researcher and project group leader at Institute for Cancer Research – was on December 16th awarded the prize Researcher-of-the-Year from the leadership at ICR for her outstanding scientific contributions. The award of 100 000 NOK is financed by the Radium Hospital Foundation (Radiumhospitalets legater) and is a personal scholarship for stimulating further excellence in research. 

Units and subpages

View all subunitsHide all subunits